Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding DMK Pharmaceuticals Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of DMK: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4348+5
Shares12.9M12.7M−109.2K (−0.8%)
Value$2.55M$2.16M−$397.2K (−15.6%)

New holders (11)

Institutions that held DMK Pharmaceuticals Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to DMK in Q4 2022
InstitutionSharesValue% of portfolio
Jane Street Group, LLC96,824$16.4K0.00%
UBS Group AG40,958$6.96K0.00%
RVW Wealth, LLC19,000$3.22K0.00%
HRT Financial LP13,186$2.00K0.00%
Hollencrest Capital Management2,000$3390.00%
Belvedere Trading LLC1,541$2600.00%
Belpointe Asset Management LLC900$1520.00%
EverSource Wealth Advisors, LLC620$1050.00%
The PNC Financial Services Group, Inc.200$340.00%
Royal Bank of Canada56$00.00%
GWM Advisors LLC2,700$00.00%

Sold out (6)

Institutions that held DMK Pharmaceuticals Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of DMK in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Citadel Advisors LLC145,939$29.0K
Charles Schwab Investment Management Inc56,257$12.0K
Avantax Advisory Services, Inc.22,000$4.00K
Cetera Investment Advisers10,200$2.00K
Allworth Financial LP3,530$1.00K
Investors Asset Management of Georgia Inc100$0